by Rachel Montague | Aug 2, 2020 | Industry insights
Written by Jenna Stephens (Systematic Review Analyst) and Neil Webb (Head of Systematic Review) Evidence-based medicine and its standard practice When Archibald Cochrane formulated his vision for evidence-based medicine (EBM), it was driven by an absence of reliable,...
by Mark | Jun 22, 2020 | Industry insights
Written by Jenna Stephens (Systematic Review Analyst) and Tom Macmillan (Consultant – Systematic Review) In principle, the process of searching for published evidence for medical devices is no different from other health technologies. The NICE process guidelines...
by Rachel Montague | Jun 15, 2020 | Industry insights
Written by Tom Macmillan, Consultant – Systematic Review The NICE Medical Technologies Evaluation Programme (MTEP) evaluates novel medical devices and diagnostics for use within the National Health Service (NHS). There are currently 3 outputs from the...
by Rachel Montague | Nov 2, 2019 | Industry insights
Written by Chris Hellmund (Senior Medical Writer) and Neil Webb (Head of Systematic Review) A poster on this topic was presented at ISPOR Europe 2019. This blog post provides an overview of our findings.The abstract is available here. In previous blog posts, we...
by Mark | Oct 22, 2019 | Industry insights
Written by Julie Fricke (Systematic Review Analyst) and Neil Webb (Head of Systematic Review) Systematic Reviews – The Problem Although considered the gold standard of quality research, systematic literature reviews (SLRs) are very resource intensive (e.g. long...
by Rachel Montague | Oct 2, 2019 | Industry insights
Written by Chris Hellmund, Senior Medical Writer In a previous post, we discussed the origins of the NICE Highly Specialised Technologies (HST) process for the evaluation of therapies for rare diseases. In this blog, we examine the key differences between the Single...
